“Second Line Drugs Resistant Mycobacterium Tuberculosis in Multi-Drug Resistant Tuberculosis Patients”, J. Inst. Sci. Tech., vol. 22, no. 2, pp. 168–174, Apr. 2018, doi: 10.3126/jist.v22i2.19609.